Health
A BRIGHT Technological Future for Mental Health Trials
Playing games, watching movies, and paying bills through smartphones and tablets has become commonplace. Americans are used to doing almost everything through the technology in their pockets. Is mobile mental health research the next frontier in this smartphone revolution? Based on Dr. Patricia Areán’s pioneering BRIGHTEN study, research via smartphone app is already a reality.
- Read more
- 271 reads
WHO chief scientist: We are ready to tackle Zika infection in Europe
Dr Roberto Bertollini
- Read more
- 276 reads
World Bank Provides $150 Million to Combat Zika Virus In Latin America and the Caribbean
In order to support countries in Latin America and the Caribbean affected by the Zika virus outbreak, the World Bank Group announced Thursday that it has made US$150 million immediately available.
- Read more
- 276 reads
NIH-supported trials test hormonal therapy in older men with low testosterone levels
A preliminary study of testosterone therapy in older men with low levels of the hormone and clinical conditions to which low testosterone might contribute, found that restoring levels to those of healthy young men improved sexual function. Treatment had a smaller effect on other aspects of health, such as the ability to walk or the sense of vitality. These initial results of the Testosterone Trials (T Trials), a group of studies supported primarily by the National Institutes of Health, and report the results of the first three of seven double-blind, placebo-controlled trials.
- Read more
- 291 reads
Extremely Small Preemies May Face Bullying, Mental Health Risks
- Read more
- 270 reads
Diabetes drug may prevent recurring strokes
Illustration of an ischemic stroke, which occurs when a brain blood vessel gets blocked. The gray area represents brain tissue that is not receiving nutrients as a result of the stroke.
http://www.nih.gov/news-events/news-releases/diabetes-drug-may-prevent-r...
- Read more
- 284 reads
Diabetes drug may prevent recurring strokes
Pioglitazone, a drug used for type 2 diabetes, may prevent recurrent stroke and heart attacks in people with insulin resistance but without diabetes. The results of the Insulin Resistance Intervention after Stroke (IRIS) trial, presented at the International Stroke Conference 2016 in Los Angeles, suggest a potential new method to prevent stroke and heart attack in high-risk patients who have already had one stroke or transient ischemic attack. This large, international study was supported by the National Institutes of Health’s National Institute of Neurological Disorders and Stroke (NINDS).
- Read more
- 291 reads
Study: Getting Patients Out of Bed Soon After Stroke Is Good Medicine
- Read more
- 305 reads
More Evidence Smog May Raise Stroke Risk
- Read more
- 315 reads
Pot Smokers Susceptible to Other Addictions, Study Finds
- Read more
- 332 reads
Human Rights
Fostering a More Humane World: The 28th Eurasian Economic Summi
Conscience, Hope, and Action: Keys to Global Peace and Sustainability
Ringing FOWPAL’s Peace Bell for the World:Nobel Peace Prize Laureates’ Visions and Actions
Protecting the World’s Cultural Diversity for a Sustainable Future
Puppet Show I International Friendship Day 2020